-34.6%
MP vs MRNA
+945.0%
-979.6%
-50.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.1% | +13.1% | -18.2% | -5.5% |
| 7D | -12.5% | +20.6% | -33.2% | -13.1% |
| 30D | -23.3% | +27.1% | -50.5% | -24.1% |
| 3M | -24.4% | +353.4% | -377.7% | -30.6% |
| 6M | -45.8% | +446.3% | -492.0% | -53.0% |
| YTD | -28.9% | +776.2% | -805.1% | -44.1% |
| 1Y | -34.6% | +987.9% | -1,022.5% | -51.6% |
| All | -34.6% | +945.0% | -979.6% | -51.6% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling